BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32026103)

  • 1. The CLEAR (Considering Leading Experts' Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention.
    Wong KHF; Bosanquet DC; Ambler GK; Qureshi MI; Hinchliffe RJ; Twine CP;
    CVIR Endovasc; 2019 Nov; 2(1):37. PubMed ID: 32026103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet and Anticoagulant Use in Randomised Trials of Patients Undergoing Endovascular Intervention for Peripheral Arterial Disease: Systematic Review and Narrative Synthesis.
    Qureshi MI; Li HL; Ambler GK; Wong KHF; Dawson S; Chaplin K; Cheng HY; Hinchliffe RJ; Twine CP
    Eur J Vasc Endovasc Surg; 2020 Jul; 60(1):77-87. PubMed ID: 32265113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction to: The CLEAR (Considering Leading Experts' Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention.
    Wong KHF; Bosanquet DC; Ambler GK; Qureshi MI; Hinchliffe RJ; Twine CP;
    CVIR Endovasc; 2020 Nov; 3(1):87. PubMed ID: 33245460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures.
    Allemang MT; Rajani RR; Nelson PR; Hingorani A; Kashyap VS
    Ann Vasc Surg; 2013 Jan; 27(1):62-7. PubMed ID: 22981017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single versus dual antiplatelet therapy following peripheral arterial endovascular intervention for chronic limb threatening ischaemia: Retrospective cohort study.
    Chinai N; Ambler GK; Wardle BG; Locker D; Bosanquet D; Goyal N; Chick C; Hinchliffe RJ; Twine CP
    PLoS One; 2020; 15(6):e0234271. PubMed ID: 32525925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet therapy in endovascular surgery: the RENDOVASC study.
    Matas M; Domínguez González JM; Montull E
    Ann Vasc Surg; 2013 Feb; 27(2):168-77. PubMed ID: 23380550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
    Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L; Ghouri MA; Kovacs F
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002071. PubMed ID: 22895926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
    Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease.
    Marulanda K; Duchesneau E; Patel S; Browder SE; Caruso DM; Agala CB; Kindell DG; Curcio J; Kibbe MR; McGinigle K
    J Vasc Surg; 2022 Oct; 76(4):1021-1029.e3. PubMed ID: 35700858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice patterns of dual antiplatelet therapy after lower extremity endovascular interventions.
    Kim TI; Chen JF; Orion KC
    Vasc Med; 2019 Dec; 24(6):528-535. PubMed ID: 31686603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical practice of dual antiplatelet therapy after percutaneous peripheral arterial interventions in Germany].
    Baumhäkel M; Kindermann M
    Dtsch Med Wochenschr; 2016 Jan; 141(2):e24-31. PubMed ID: 26800077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of venous thromboembolism in patients with peripheral arterial disease after endovascular intervention.
    Kindell DG; Marulanda K; Caruso DM; Duchesneau E; Agala C; Farber M; Marston WA; McGinigle KL
    J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):61-69. PubMed ID: 36182086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in Antithrombotic Therapy after Infrainguinal Lower Extremity Bypass.
    Brahmandam A; Lee M; Bellamkonda K; Provance JB; Sumpio B; Ochoa Chaar CI; Smolderen KG; Mena-Hurtado C; Guzman RJ
    Ann Vasc Surg; 2023 Jan; 88():51-62. PubMed ID: 36245106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbrella review and meta-analysis of antiplatelet therapy for peripheral artery disease.
    Ambler GK; Waldron CA; Contractor UB; Hinchliffe RJ; Twine CP
    Br J Surg; 2020 Jan; 107(1):20-32. PubMed ID: 31808552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
    Harris J; Pouwels KB; Johnson T; Sterne J; Pithara C; Mahadevan K; Reeves B; Benedetto U; Loke Y; Lasserson D; Doble B; Hopewell-Kelly N; Redwood S; Wordsworth S; Mumford A; Rogers C; Pufulete M
    Health Technol Assess; 2023 May; 27(8):1-257. PubMed ID: 37435838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy.
    Aboyans V; Bauersachs R; Mazzolai L; Brodmann M; Palomares JFR; Debus S; Collet JP; Drexel H; Espinola-Klein C; Lewis BS; Roffi M; Sibbing D; Sillesen H; Stabile E; Schlager O; De Carlo M
    Eur Heart J; 2021 Oct; 42(39):4013-4024. PubMed ID: 34279602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases.
    De Carlo M; Schlager O; Mazzolai L; Brodmann M; Espinola-Klein C; Staub D; Aboyans V; Sillesen H; Debus S; Venermo M; Belch J; Ferrari M; De Caterina R
    Eur Heart J Cardiovasc Pharmacother; 2023 Apr; 9(3):201-207. PubMed ID: 36208909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic Therapy for Peripheral Revascularisation.
    De Carlo M; Angelillis M; Liga R
    Curr Vasc Pharmacol; 2020; 18(3):223-236. PubMed ID: 30727899
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.